Catalyst Pharma: Awaiting Key Clinical Trial Results For CPP-109 For Treating … – Seeking Alpha
|
Catalyst Pharma: Awaiting Key Clinical Trial Results For CPP-109 For Treating ...
Seeking Alpha Other drugs in phase II trials for this indication are Teva's (TEVA) narcolepsy drug modafinil and a cocaine vaccine from Xenova Group. There may be other drugs in development as I have not yet done a thorough competitive analysis. |